The FY2025 (Dec) proxy of Xeris Biopharma Holdings names 16 peer companies for pay. Pay versus performance data of Xeris Biopharma Holdings for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Mirum Pharmaceuticals | ||
| Adma Biologics | ||
| Travere Therapeutics | ||
| UroGen Pharma | ||
| Ani Pharmaceuticals | Not disclosed | Not disclosed |
| Aquestive Therapeutics | Not disclosed | Not disclosed |
| Assertio | Not disclosed | Not disclosed |
| Coherus BioSciences | Not disclosed | Not disclosed |
| Collegium Pharmaceuticals | Not disclosed | Not disclosed |
| Harrow | Not disclosed | Not disclosed |
| Ironwood Pharmaceuticals | Not disclosed | Not disclosed |
| Karyopharm Therapeutics | Not disclosed | Not disclosed |
| MacroGenics | Not disclosed | Not disclosed |
| Ocular Pharmaceuticals | Not disclosed | Not disclosed |
| Rhythm Pharmaceuticals | Not disclosed | Not disclosed |
| Y-mAbs Therapeutics | Not disclosed | Not disclosed |
16 companies
Changes by year
FY2025 (Dec) proxy
- AddedIronwood Pharmaceuticalspay peer groupIronwood Pharmaceuticals was subsequently added to the peer group for its “fit” relative to other companies in the peer group in terms of financial profile and business/products
- RemovedDeciphera Pharmaceuticalspay peer groupDeciphera Pharmaceuticals was acquired by ONO Pharmaceuticals in June 2024, therefore removed from the peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.